- Home
- SILO vs GSIW Comparison
SILO vs GSIW Comparison
Compare SILO & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- GSIW
- Stock Information
- Founded
- SILO 2010
- GSIW 2016
- Country
- SILO United States
- GSIW Hong Kong
- Employees
- SILO N/A
- GSIW N/A
- Industry
- SILO Apparel
- GSIW
- Sector
- SILO Consumer Discretionary
- GSIW
- Exchange
- SILO Nasdaq
- GSIW Nasdaq
- Market Cap
- SILO 8.8M
- GSIW 12.3M
- IPO Year
- SILO N/A
- GSIW 2023
- Fundamental
- Price
- SILO $1.31
- GSIW $0.46
- Analyst Decision
- SILO
- GSIW
- Analyst Count
- SILO 0
- GSIW 0
- Target Price
- SILO N/A
- GSIW N/A
- AVG Volume (30 Days)
- SILO 126.3K
- GSIW 491.0K
- Earning Date
- SILO 03-18-2025
- GSIW 12-31-2024
- Dividend Yield
- SILO N/A
- GSIW N/A
- EPS Growth
- SILO N/A
- GSIW N/A
- EPS
- SILO N/A
- GSIW N/A
- Revenue
- SILO $72,102.00
- GSIW $1,313,795.00
- Revenue This Year
- SILO $1.86
- GSIW N/A
- Revenue Next Year
- SILO N/A
- GSIW N/A
- P/E Ratio
- SILO N/A
- GSIW N/A
- Revenue Growth
- SILO N/A
- GSIW N/A
- 52 Week Low
- SILO $0.77
- GSIW $0.43
- 52 Week High
- SILO $4.50
- GSIW $12.30
- Technical
- Relative Strength Index (RSI)
- SILO 41.82
- GSIW 42.82
- Support Level
- SILO $1.31
- GSIW $0.43
- Resistance Level
- SILO $1.34
- GSIW $0.53
- Average True Range (ATR)
- SILO 0.10
- GSIW 0.06
- MACD
- SILO -0.01
- GSIW -0.00
- Stochastic Oscillator
- SILO 25.00
- GSIW 12.16
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.